120 related articles for article (PubMed ID: 38703565)
1. Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Ding X; Liu H; Xu Q; Ji T; Chen R; Liu Z; Dai J
Int Immunopharmacol; 2024 Jun; 134():112162. PubMed ID: 38703565
[TBL] [Abstract][Full Text] [Related]
2. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
3. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
4. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
5. [Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis
and Lung Adenocarcinoma].
Wang J; Lu L; He X; Ma L; Chen T; Li G; Yu H
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):669-683. PubMed ID: 37985153
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and
Zeng L; Tang Y; Zhang Y; Yue L; Ma G; Ye X; Yang L; Chen K; Zhou Q
Front Immunol; 2023; 14():1288098. PubMed ID: 37928522
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.
Qian W; Cai X; Qian Q; Zhang X
Biomed Res Int; 2021; 2021():5545312. PubMed ID: 34285914
[TBL] [Abstract][Full Text] [Related]
8. Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents.
Zhou X; Tan F; Zhang S; Zhang T
Funct Integr Genomics; 2023 Nov; 23(4):346. PubMed ID: 37996625
[TBL] [Abstract][Full Text] [Related]
9. Weighted Gene Coexpression Network Analysis Identifies Key Genes and Pathways Associated with Idiopathic Pulmonary Fibrosis.
Wang Z; Zhu J; Chen F; Ma L
Med Sci Monit; 2019 Jun; 25():4285-4304. PubMed ID: 31177264
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Mizuno K; Mataki H; Seki N; Kumamoto T; Kamikawaji K; Inoue H
J Hum Genet; 2017 Jan; 62(1):57-65. PubMed ID: 27488441
[TBL] [Abstract][Full Text] [Related]
11. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
14. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
18. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
19. Identification of shared molecular mechanisms and diagnostic biomarkers between heart failure and idiopathic pulmonary fibrosis.
Zhang P; Geng L; Zhang K; Liu D; Wei M; Jiang Z; Lu Y; Zhang T; Chen J; Zhang J
Heliyon; 2024 Apr; 10(8):e30086. PubMed ID: 38699746
[TBL] [Abstract][Full Text] [Related]
20. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
